Loading market dashboard
ABVC BioPharma, Inc.
ABVCHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
ABVC BioPharma, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2026 | $35.28M | $35.28M - $35.28M | -$21.17M | $1.30 | 1 |
| Dec 2025 | $4.17M | $4.17M - $4.17M | -$2.50M | -$4.60 | 1 |
| Dec 2024 | $14.51M | $14.51M - $14.51M | -$8.71M | -$4.40 | 1 |
| Dec 2023 | $697.8K | $249.0K - $1.15M | -$697.8K | -$2.00 | 1 |
| Dec 2022 | $394.1K | $394.1K - $394.1K | -$394.1K | -$5.20 | 1 |
| Dec 2021 | $588.9K | $588.9K - $588.9K | -$588.9K | -$2.30 | 1 |
| Dec 2020 | $537.6K | $537.6K - $537.6K | -$537.6K | -$3.40 | 1 |